Sponsors (6)
Introduced January 3, 2025 by Vernon G. Buchanan · Last progress January 3, 2025
The bill expedites a detailed, public review to identify ways to reduce veteran suicides and improve prescribing safety, at the cost of privacy risks, added resource demands on VA and state agencies, and reliance on recommendations that are not binding.
Veterans: Rapid, detailed review of suicide and related deaths will identify patterns in care and prescribing to guide targeted prevention, treatment improvements, and updates to VA clinical guidelines to reduce risky prescribing and polypharmacy.
Veterans, families, and the public: Requires a timely public report to Congress and public release of findings, increasing transparency and accountability around veteran deaths and VA practices.
State and tribal health partners: Identifies gaps and best practices in death certificate and PDMP data sharing to enable better interagency coordination and improve surveillance and response.
Veterans: Publication of disaggregated clinical and toxicology data could risk privacy and confidentiality for individual veterans and families.
Taxpayers and VA staff: Compiling the required detailed data and meeting tight deadlines will require VA and NAS resources and staff time, potentially diverting resources from care delivery and imposing fiscal costs.
Veterans: The review's findings and recommendations are non‑binding, so meaningful changes to VA prescribing practices or staffing may be delayed or not occur without further action.
Based on analysis of 2 sections of legislative text.
Requires the Department of Veterans Affairs to contract with the National Academies to conduct a detailed, retrospective review of deaths (suicide, violent, accidental) among covered veterans who died during the five years before enactment. The review must collect and analyze quantitative and qualitative data on clinical care, prescribing, toxicology, diagnostics, treatment, staffing, interagency coordination, data sharing, and other factors, with results publicly reported to Congress within set deadlines.